Codes / ICD10CM / T83.59XS

T83.59XS Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, sequela

Summary

This condition represents a late effect (sequela) of an infection and inflammatory response associated with prosthetic devices, implants, or grafts in the urinary system. It arises from prior infection or inflammation at the site of these devices, leading to residual complications or chronic changes. The sequela may involve persistent symptoms, structural damage, or functional impairment related to the initial infection.

Causes

The primary cause is a prior infection or inflammatory reaction at the site of a prosthetic device, implant, or graft in the urinary system. This can result from microbial colonization, contamination during insertion, or the body's reaction to foreign material. Common pathogens include bacteria like E. coli or Staphylococcus species. The sequela develops as a consequence of the initial infection, potentially due to incomplete resolution, chronic inflammation, or tissue damage.

Risk Factors

  • Use of prosthetic devices, implants, or grafts in the urinary system.
  • Prolonged device placement.
  • Compromised immune system.
  • Poor hygiene or maintenance of the device.
  • Previous urinary tract infections or surgeries.
  • Inadequate treatment of the initial infection.

Symptoms

  • Persistent pain or discomfort in the urinary area.
  • Recurrent fever, chills, or malaise.
  • Chronic cloudy, foul-smelling urine.
  • Increased urinary frequency or urgency.
  • Swelling or redness around the device site.
  • Structural or functional changes in the urinary system (e.g., obstruction, incontinence).

Diagnosis

Diagnosis is based on clinical history of prior infection or inflammation related to a prosthetic device, implant, or graft in the urinary system. Physical examination, imaging studies (e.g., ultrasound, CT), and urine cultures may be used to assess residual inflammation or complications. Documentation of the initial event and its sequelae is critical for confirmation.

Treatment Options

Treatment focuses on managing residual symptoms and complications. This may include antibiotics for persistent infection, anti-inflammatory medications, or surgical intervention to address structural issues. Device removal or revision may be necessary in severe cases. Management is tailored to the specific sequelae and patient needs.

Prognosis and Follow-Up

Prognosis depends on the severity of the sequela and response to treatment. Chronic complications may require long-term management. Regular follow-up is essential to monitor for recurrence, device integrity, and functional outcomes. Early intervention can improve prognosis and prevent further deterioration.

Complications

  • Chronic urinary tract infection.
  • Device malfunction or failure.
  • Structural damage to the urinary system (e.g., strictures, fistulas).
  • Renal impairment or failure.
  • Persistent pain or incontinence.
  • Systemic infection or sepsis.

Lifestyle & Prevention

  • Maintain strict hygiene around the device site.
  • Follow prescribed device care instructions.
  • Promptly address any signs of infection (e.g., fever, discharge).
  • Avoid activities that may compromise device integrity.
  • Stay hydrated to support urinary tract health.

When to Seek Professional Help

Seek medical attention if you experience persistent symptoms (e.g., fever, pain, changes in urine), signs of infection (e.g., redness, swelling), or device-related complications (e.g., leakage, malfunction). Early evaluation can prevent progression and improve outcomes.

Tips for Medical Coders

Document the specific prosthetic device, implant, or graft involved and confirm the sequela status. Ensure the initial infection or inflammatory event is clearly linked to the current condition. Code T83.59XS is used for the sequela; verify that the "sequela" designation aligns with clinical documentation of residual effects. Include details on device type, location, and any contributing factors to support accurate coding.

Book a walkthrough

T83.59XS policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.